Submissions To China's Fast-Track System For Innovative Device Approval Swell
This article was originally published in Clinica
Executive Summary
The number of applications going through China’s fast-track regulatory process for evaluating innovative medical devices is growing at a steady pace with 46 products admitted for evaluation so far. Of these 17 were submitted in 2014 (of which six have been approved) and 29 in 2015 (of which two have been approved). The fast track route was launched by the China Food and Drug Administration on March 1, 2014.
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EMA Hopes New Requirement Will Make Companies Stick To Their Filing Plans
An additional form that marketing authorization applicants must now complete during the pre-submission stage emphasizes the importance of companies providing accurate information on their intended submission date.
EMA To Get The Ball Rolling On Making CTIS Global
The European Medicines Agency wants to further improve the visibility of data in the Clinical Trials Information System by establishing it as a World Health Organization primary registry.